IDXX Revenue 2026

Annual and quarterly sales data for Idexx Laboratories Inc

Latest Annual Revenue

$3.90B

2024-12-31

YoY Growth

+6.5%

vs. previous year

4-Year CAGR

9.5%

compound growth

Annual Revenue History

2024-12-31

$3.90B

YoY Growth

+6.5%

2023-12-31

$3.66B

YoY Growth

+8.7%

2022-12-31

$3.37B

YoY Growth

+4.7%

2021-12-31

$3.22B

YoY Growth

+18.8%

2020-12-31

$2.71B

Quarterly Revenue Breakdown

2025-09-30

$1.11B

2025-06-30

$1.11B

2025-03-31

$998M

2024-09-30

$976M

2024-06-30

$1.00B

2024-03-31

$964M

2023-09-30

$916M

2023-06-30

$944M

Revenue by Segment

Total Revenue$3.90B (100.0%)

Get Full IDXX Financial Analysis

View complete income statements, balance sheets, and AI-powered insights

Frequently Asked Questions

What is IDXX's revenue?

IDXX (Idexx Laboratories Inc) reported $3.90 billion in revenue for 2024-12-31. This represents a 6.5% increase compared to the previous year.

How much revenue does IDXX make per year?

Idexx Laboratories Inc generates approximately $3.90 billion in annual revenue based on the most recent fiscal year ending 2024-12-31.

Is IDXX revenue growing?

Yes, IDXX's revenue is growing. The company achieved 6.5% revenue growth year-over-year. Over the past 4 years, revenue has grown at a compound annual growth rate (CAGR) of 9.5%.

What is IDXX's quarterly revenue?

IDXX reported $1.11 billion in revenue for the most recent quarter (2025-09-30).

What are IDXX's revenue sources?

IDXX's revenue comes from multiple segments: Total Revenue. See the revenue breakdown below for detailed segment analysis.

How does IDXX compare to competitors in revenue?

IDXX generates $3.90 billion in annual revenue in the Health Care sector. Compare IDXX to competitors using our stock comparison tool to see relative market share and growth rates.

Disclaimer: Revenue data is based on publicly filed financial statements. Historical performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.

Explore Categories